Real-world effectiveness and safety of a recombinant factor VIII Fc in patients with haemophilia A by disease severity: Pooled analysis (A-SURE/PREVENT)

被引：0
|
作者：
Holme, P. A. [1 ]
Alvarez Roman, M. T. [2 ]
Tagliaferri, A. [3 ]
Oldenburg, J. [4 ]
Halimeh, S. [5 ]
Lauer, S. [6 ]
Fusser, M. [6 ]
Gresko, E. [7 ]
Lethagen, S. [6 ,8 ]
机构：
[1] Univ Oslo, Oslo Univ Hosp, Inst Clin Med, Dept Haematol, Oslo, Norway
[2] La Paz Univ Hosp IdiPaz, Dept Haematol, Madrid, Spain
[3] Univ Hosp Parma, Reg Reference Ctr Inherited Bleeding Disorders, Parma, Italy
[4] Univ Clin Bonn, Inst Expt Haematol & Transfus Med, Bonn, Germany
[5] erinnungszentrum Rhein Ruhr, Duisburg, Germany
[6] Sobi, Stockholm, Sweden
[7] Sobi, Basel, Switzerland
[8] Univ Copenhagen, Copenhagen, Denmark
来源：
HAEMOPHILIA | 2024年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO099
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [1] Real-world effectiveness and safety of a recombinant factor VIII Fc in patients with haemophilia A by age groups: pooled analysis (A-SURE/PREVENT)
    Roman, M. T. Alvarez
    Oldenburg, J.
    Ettingshausen, C. Escuriola
    Lauer, S.
    Fusser, M.
    Gresko, E.
    Lethagen, S.
    HAEMOPHILIA, 2024, 30 : 77 - 77
  • [2] Design of a prospective observational study on the effectiveness and real-world usage of recombinant factor VIII Fc (rFVIIIFc) compared with conventional products in haemophilia A: the A-SURE study
    Oldenburg, Johannes
    Hay, Charles R. M.
    Jimenez-Yuste, Victor
    Peyvandi, Flora
    Schved, Jean-Francois
    Szamosi, Johan
    Winding, Bent
    Lethagen, Stefan
    BMJ OPEN, 2019, 9 (05):
  • [3] FINAL DATA FROM THE PREVENT STUDY EVALUATING REAL-WORLD USAGE AND EFFECTIVENESS OF A RECOMBINANT FACTOR VIII FC AND RECOMBINANT FACTOR IX FC IN HAEMOPHILIA A OR B IN GERMANY
    Bidlingmaier, C.
    Heller, C.
    Langer, F.
    Miesbach, W.
    Schotz, U.
    Oldenburg, J.
    Roehss, J.
    Falk, A.
    Santagostino, E.
    Tiede, A.
    HAEMOPHILIA, 2023, 29 : 48 - 49
  • [4] Real-world usage and effectiveness of recombinant factor IX Fc in haemophilia B from the B-SURE study in France
    Chambost, Herve
    Repesse, Yohann
    Genre-Volot, Fabienne
    Desprez, Dominique
    Castet, Sabine Marie
    Vanderbecken, Stephane
    Zidi, Meriem
    Gandossi, Corinne
    Nuesch, Eveline
    Palmborg, Helena
    Santagostino, Elena
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2025, 16
  • [5] BASELINE DATA FROM A-SURE: A 24-MONTH PROSPECTIVE, NON-INTERVENTIONAL STUDY COMPARING EFFECTIVENESS OF RECOMBINANT FACTOR VIII FC (RFVIIIFC) WITH CONVENTIONAL FACTOR VIII (CONVFVIII) PROPHYLAXIS IN HAEMOPHILIA A
    Hay, C.
    Jimenez-Yuste, V.
    Oldenburg, J.
    Peyvandi, F.
    Schved, J. -F.
    Tagliaferri, A.
    Malmstrom, H.
    Winding, B.
    Lethagen, S.
    HAEMOPHILIA, 2020, 26 : 67 - 67
  • [6] Real-world safety and effectiveness of recombinant porcine sequence factor VIII in acquired haemophilia A: A non-interventional, post-authorization safety study
    Tarantino, Michael D.
    Hardesty, Brandon
    Metjian, Ara
    Ortel, Thomas L.
    Chen, Jie
    Badejo, Kayode
    Ma, Alice
    Cuker, Adam
    Rajasekhar, Anita
    Friedman, Kenneth D.
    Janbain, Maissaa
    HAEMOPHILIA, 2023, 29 (05) : 1259 - 1268
  • [7] FINAL DATA FROM B-SURE, A FRENCH MULTICENTRE STUDY IN PATIENTS WITH HAEMOPHILIA B, EVALUATING REAL-WORLD USAGE AND EFFECTIVENESS OF RECOMBINANT FACTOR IX FC (RFIXFC)
    Chambost, H.
    Repesse, Y.
    Volot, F. Genre
    Desprez, D.
    Castet, S.
    Vanderbecken, S.
    Zidi, M.
    Rohss, J.
    Palmborg, H.
    Santagostino, E.
    HAEMOPHILIA, 2023, 29 : 57 - 58
  • [8] Pooled Analysis on the Effectiveness and Safety of Lipegfilgrastim in Patients With Urological Malignancies in the Real-World Setting
    Merseburger, Axel S.
    Geiges, Goetz
    Klier, Joerg
    Wiesholzer, Martin
    Pichler, Petra
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] Real-world usage and effectiveness of recombinant factor VIII/ factor IX Fc in hemophilia A/B: final data from the 24-month, prospective, noninterventional PREVENT study in Germany
    Bidlingmaier, Christoph
    Heller, Christine
    Langer, Florian
    Miesbach, Wolfgang
    Scholz, Ute
    Oldenburg, Johannes
    Nueesch, Eveline
    Palmborg, Helena
    Santagostino, Elena
    Tiede, Andreas
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (05)
  • [10] Effectiveness and safety of Ustekinumab for Crohn's disease; systematic review and pooled analysis of real-world evidence
    Engel, Tal
    Yung, Diana E.
    Ma, Christopher
    Pariente, Benjamin
    Wils, Pauline
    Eliakim, Rami
    Ungar, Bella
    Ben-Horin, Shomron
    Kopylov, Uri
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (09) : 1232 - 1240
12345